Consider the recent sell-off in Oscar Health (OSCR) as a potential buying opportunity, as the stock appears fundamentally undervalued after being unfairly punished in a sector-wide drop. The speaker has strong conviction, calling OSCR "too cheap to ignore" and personally adding to his position on the dip. For those investing in MicroStrategy (MSTR), view short-term price underperformance relative to Bitcoin as a bullish sign that the company is raising capital to acquire more assets. While the new Solana Staking ETF (SSK) offers easy access, investors should be wary of its very high fees and tax-inefficient structure. For long-term growth, buying and staking Solana (SOL) directly may be a more cost-effective strategy than using the new ETF.

MicroStrategy (MSTR)

• The speaker highlights that MSTR is an extremely volatile stock, with daily moves of +/- 8% being normal and expected. This volatility is directly tied to the price movements of Bitcoin.
• He explains that when MSTR's stock price rises less than Bitcoin's price on a given day, it is likely because the company is conducting an "at-the-market" (ATM) offering.
  • This means the company is selling new shares of its stock to raise cash.
  • The speaker views this as a bullish activity, as it allows MSTR to take advantage of its high premium to its net asset value (NAV), which he estimates is currently around 1.75x to 1.85x.
  • This strategy allows the company to "sell a dollar for $1.75" and use the proceeds to aggressively acquire more Bitcoin, which is its core mission.
• The speaker contrasts MSTR's aggressive accumulation strategy favorably against other Bitcoin treasury companies that he believes are too slow to acquire more assets.

Takeaways

• Investors should be prepared for extreme volatility with MSTR and not panic during large daily price swings. The stock's performance is fundamentally linked to Bitcoin.
• The speaker suggests that short-term underperformance of MSTR relative to Bitcoin can be a positive sign, indicating that the company is raising capital to buy more Bitcoin at a favorable premium.
• The core investment thesis for MSTR is a belief in its strategy of using its stock premium to aggressively and continuously increase its Bitcoin holdings.

Tesla (TSLA)

• The stock rose +5% after reporting vehicle delivery numbers that beat the pessimistic expectations heavily circulated in the media.
• The speaker points out that many news outlets and analysts were forecasting deliveries as low as 360,000 vehicles.
• The actual reported number was 384,000 vehicles, which represents a 7% beat over the widely publicized negative forecast.
• He argues that Tesla is one of the "most hated stocks out there" and is often subject to a negative media narrative, which can create volatility.
• The speaker, who holds the stock, emphasizes the importance of not making emotional trading decisions based on negative headlines.

Takeaways

• Investors should be cautious of the media narrative surrounding Tesla, as it can be overly negative and may not reflect the company's actual performance.
• The recent stock price increase was driven by the company beating pessimistic delivery expectations. This highlights the potential for opportunity when market sentiment is low but fundamentals deliver.
• The speaker suggests focusing on the company's reported data rather than being swayed by emotional or biased headlines.

Oscar Health (OSCR)

• The stock fell -19% in a "sympathy fall" alongside other health insurance stocks. The sector-wide sell-off was triggered by Centene (CNC), which dropped 40% after lowering its guidance.
• The speaker believes OSCR was unfairly punished in a "basket trade" where investors sold the entire sector, with smaller-cap stocks like Oscar being hit the hardest.
• He states that he is invested in OSCR not because he likes the insurance industry, but because his analysis shows the stock is "dirt-to-deer cheap" and "too cheap to ignore" based on its valuation metrics.
• He dismisses a recent analyst's "underweight" rating, which was attributed to "speculative retail interest," arguing that retail investors are often early in identifying promising stocks.
• The speaker confirmed that he personally bought more shares of OSCR during the price drop.

Takeaways

• Oscar Health's significant price drop may not be related to its own company-specific news, but rather to negative sentiment across the entire health insurance sector.
• This could represent a potential buying opportunity for investors who believe the sell-off was unjustified and that the stock is fundamentally undervalued.
• The speaker has a strong bullish conviction based on valuation, viewing the current price as an attractive entry point.

Solana (SOL) & Rex Osprey SOL Staking ETF (SSK)

• A new Solana Staking ETF with the ticker SSK has launched, which the speaker sees as a significant step for crypto going mainstream.
• The primary question for an investor is whether they believe Solana will be a winning blockchain technology compared to competitors like Ethereum.
• Positive Aspect: The ETF allows investors to earn staking rewards, which is a major advantage over previous crypto futures ETFs.
• Concerns & Drawbacks:
  • High Fees: The ETF has a combined expense ratio of 1.4%, which the speaker calls "very expensive" and nearly 10 times higher than typical Bitcoin ETFs (around 0.20%).
  • Tax Inefficiency: Staking rewards are paid out as distributions (like dividends) instead of being automatically reinvested and compounded within the ETF wrapper. This means investors will likely have to pay taxes on the rewards annually, which significantly reduces the power of long-term compounding.
  • No Leverage: The ETF has a 100% maintenance ratio, meaning it cannot be used as collateral to borrow against.

Takeaways

• The SSK ETF offers a simple, accessible way to gain exposure to Solana and its staking yield without the technical challenges of managing your own crypto wallet.
• However, investors should weigh the convenience against the significant drawbacks: very high fees and a tax-inefficient structure that will hinder long-term returns compared to tax-deferred compounding.
• For investors comfortable with the technology, buying SOL directly and staking it themselves may be a more cost-effective and tax-efficient strategy. It is also possible that competing ETFs with lower fees will launch in the future.

Investment Theme: Retail Investors vs. Wall Street

• The speaker repeatedly defends retail investors against the "classic condescension" from Wall Street analysts.
• He uses Rocket Lab (RKLB) as a prime example of retail investors being right. The retail community was very bullish on RKLB when it was a $4 stock, and it has since increased 10x.
• He argues that retail investors are often early in identifying major trends and successful companies, sometimes years before professional analysts catch on.
• The speaker cautions that retail can sometimes be too early, but their analysis should not be dismissed.

Takeaways

• Following the sentiment and research of dedicated retail investor communities can be a valuable source of investment ideas.
• Retail investors are often early adopters and can identify high-growth opportunities before they become mainstream.
• While not a replacement for your own research, dismissing a stock simply because it is popular with "retail" could mean missing out on significant gains, as exemplified by stocks like Rocket Lab.